Last reviewed · How we verify

SUPREP Bowel Prep Kit

Braintree Laboratories · FDA-approved active Small molecule

SUPREP works by drawing water into the intestines to flush out the contents, preparing the bowel for colonoscopy.

SUPREP Bowel Prep Kit is a prescription medication used for bowel cleansing before colonoscopy. It is manufactured by Braintree Laboratories and does not have an FDA label. The kit contains polyethylene glycol 3350, sodium sulfate, sodium chloride, and potassium chloride. Common side effects include nausea, vomiting, abdominal distension, and headache. SUPREP is generally well-tolerated but has specific contraindications and warnings. It competes in the bowel preparation market with other products like MoviPrep and Golytely.

At a glance

Generic nameSUPREP Bowel Prep Kit
SponsorBraintree Laboratories
Drug classOsmotic laxative
TargetIntestinal lumen
ModalitySmall molecule
Therapeutic areaMetabolic
PhaseFDA-approved

Mechanism of action

The osmotic laxative properties of polyethylene glycol 3350 and the electrolytes in SUPREP draw water into the intestines, causing a large volume of fluid to move through the colon and cleanse it.

Approved indications

Common side effects

Key clinical trials

Patents

PatentExpiryType
US7820198B2

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results
FDA Orange BookPatents + exclusivity

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: